NO20043211L - Imidazo [1,2-a]pyridinderivat - Google Patents
Imidazo [1,2-a]pyridinderivatInfo
- Publication number
- NO20043211L NO20043211L NO20043211A NO20043211A NO20043211L NO 20043211 L NO20043211 L NO 20043211L NO 20043211 A NO20043211 A NO 20043211A NO 20043211 A NO20043211 A NO 20043211A NO 20043211 L NO20043211 L NO 20043211L
- Authority
- NO
- Norway
- Prior art keywords
- imidazo
- pyridine derivative
- activity
- antifungal
- solvat
- Prior art date
Links
- 150000005234 imidazo[1,2-a]pyridines Chemical class 0.000 title 1
- 229920002498 Beta-glucan Polymers 0.000 abstract 1
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002022767 | 2002-01-31 | ||
| PCT/JP2003/000913 WO2004068744A1 (ja) | 2003-01-30 | 2003-01-30 | 光クロスコネクト装置及び光クロスコネクト装置の監視方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20043211L true NO20043211L (no) | 2004-10-27 |
Family
ID=27654429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043211A NO20043211L (no) | 2002-01-31 | 2004-07-28 | Imidazo [1,2-a]pyridinderivat |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050113397A1 (ko) |
| EP (1) | EP1479681A4 (ko) |
| JP (1) | JPWO2003064422A1 (ko) |
| KR (1) | KR20040077920A (ko) |
| CN (1) | CN1633434A (ko) |
| CA (1) | CA2474850A1 (ko) |
| NO (1) | NO20043211L (ko) |
| RU (1) | RU2004126320A (ko) |
| TW (1) | TW200306822A (ko) |
| WO (1) | WO2003064422A1 (ko) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005077948A1 (ja) * | 2004-02-16 | 2005-08-25 | Daiichi Pharmaceutical Co., Ltd. | 抗真菌作用複素環化合物 |
| WO2006128184A2 (en) * | 2005-05-20 | 2006-11-30 | Alantos-Pharmaceuticals, Inc. | Pyrimidine or triazine fused bicyclic metalloprotease inhibitors |
| US20070155738A1 (en) * | 2005-05-20 | 2007-07-05 | Alantos Pharmaceuticals, Inc. | Heterobicyclic metalloprotease inhibitors |
| JPWO2007020936A1 (ja) | 2005-08-17 | 2009-02-26 | 第一三共株式会社 | 抗真菌作用二環性複素環化合物 |
| EP1911752A1 (en) * | 2006-10-03 | 2008-04-16 | Lonza Ag | Process for the preparation of butyrolactones |
| MX2009009849A (es) * | 2007-03-15 | 2009-09-24 | Schering Corp | Derivados de piridazinona sustituida con piperazina utiles como inhibidores de glucano sintasa. |
| JP5147866B2 (ja) * | 2007-03-15 | 2013-02-20 | メルク・シャープ・アンド・ドーム・コーポレーション | グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 |
| EA201291114A1 (ru) * | 2010-04-27 | 2013-04-30 | Астеллас Фарма Инк. | ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-a]ПИРИДИНА |
| KR101778354B1 (ko) | 2011-08-18 | 2017-09-13 | 니뽄 신야쿠 가부시키가이샤 | 헤테로환 유도체 및 의약 |
| EA032314B1 (ru) | 2015-03-18 | 2019-05-31 | Бристол-Маерс Сквибб Компани | Трициклические гетероциклические соединения, применимые в качестве ингибиторов tnf |
| EA032315B1 (ru) | 2015-03-18 | 2019-05-31 | Бристол-Маерс Сквибб Компани | Замещенные трициклические гетероциклические соединения |
| JP6779899B2 (ja) | 2015-03-18 | 2020-11-04 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | Ｔｎｆ阻害剤として有用なヘテロ環式化合物 |
| WO2017023902A1 (en) | 2015-08-03 | 2017-02-09 | Bristol-Myers Squibb Company | Cyclic compounds useful as modulators of tnf alpha |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU622330B2 (en) * | 1989-06-23 | 1992-04-02 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides |
| AU2001252604A1 (en) * | 2000-05-01 | 2001-11-12 | Daiichi Pharmaceutical Co., Ltd. | Method of screening drug acting on cell wall |
-
2003
- 2003-01-30 TW TW092102262A patent/TW200306822A/zh unknown
- 2003-01-30 RU RU2004126320/04A patent/RU2004126320A/ru not_active Application Discontinuation
- 2003-01-30 KR KR10-2004-7011850A patent/KR20040077920A/ko not_active Application Discontinuation
- 2003-01-30 EP EP03734891A patent/EP1479681A4/en not_active Withdrawn
- 2003-01-30 WO PCT/JP2003/000912 patent/WO2003064422A1/ja active Application Filing
- 2003-01-30 CA CA002474850A patent/CA2474850A1/en not_active Abandoned
- 2003-01-30 US US10/502,971 patent/US20050113397A1/en not_active Abandoned
- 2003-01-30 JP JP2003564045A patent/JPWO2003064422A1/ja active Pending
- 2003-01-30 CN CNA038067943A patent/CN1633434A/zh active Pending
-
2004
- 2004-07-28 NO NO20043211A patent/NO20043211L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2003064422A1 (ja) | 2005-05-26 |
| KR20040077920A (ko) | 2004-09-07 |
| CN1633434A (zh) | 2005-06-29 |
| WO2003064422A1 (fr) | 2003-08-07 |
| TW200306822A (en) | 2003-12-01 |
| EP1479681A1 (en) | 2004-11-24 |
| EP1479681A4 (en) | 2006-05-10 |
| RU2004126320A (ru) | 2005-04-10 |
| US20050113397A1 (en) | 2005-05-26 |
| CA2474850A1 (en) | 2003-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO331013B1 (no) | Nye forbindelser som er anti-inflammasjons, immunomodulerende og anti-proliferative midler, anvendelse av forbindelsene samt farmasoytisk preparat | |
| ATE296826T1 (de) | Pyrazolo(1,5)pyridinderivate | |
| MXPA05009985A (es) | Ligandos de receptores de canabinoides. | |
| NO20052884L (no) | Substituerte indolpyridinforbindelser som anti-infeksjonsmidler. | |
| NO20050828L (no) | lndol-3-svovelderivater | |
| NO20045369L (no) | Nye, substituerte sulfamatanticonvulsivaderivater | |
| MXPA04004674A (es) | Ligados de los receptors de los canabinodies. | |
| RS52625B (en) | FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES | |
| RS51444B (sr) | JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa | |
| NO20043211L (no) | Imidazo [1,2-a]pyridinderivat | |
| WO2005021495A3 (en) | Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones | |
| EP1541570A4 (en) | NEW PHYSIOLOGICALLY ACTIVE SUBSTANCE | |
| NO20063576L (no) | 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes | |
| NO20051289L (no) | Lincomycinderivater som fremviser antibakteriell aktivitet. | |
| NO20061789L (no) | Aminopyridinderivater som induserbare NO-syntaseinhibitorer | |
| DK1483246T3 (da) | 5-Substituerede alkylaminopyrazolderivater som pesticider | |
| SE0200919D0 (sv) | Chemical compounds | |
| EP1097925A4 (en) | NOVEL BENZOIC ACID DERIVATIVES AND PREPARATION METHODS THEREOF | |
| WO2002024697A1 (fr) | Composes spiro et inhibiteurs de molecules d'adhesion contenant ces composes comme ingredient actif | |
| NO20052994L (no) | Nye fosforamidderivater. | |
| ATE399168T1 (de) | Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren | |
| WO2004067703A3 (en) | 5ht7 antagonists and inverse agonists | |
| NO20044466L (no) | Plasma-karboksypeptidase B-inhibitorer | |
| EP1803719A4 (en) | 1,5-DIHETEROCYCLUS-1H-triazole | |
| NO20070421L (no) | Radiosensitiviserende middel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |